Evidence map›Paper›PMID 28843396›Full record

ArticleActa tropica2017

Profiling gene expression of antimony response genes in Leishmania (Viannia) panamensis and infected macrophages and its relationship with drug susceptibility.

Maria Claudia Barrera, Laura Jimena Rojas, Austin Weiss, Olga Fernandez, Diane McMahon-Pratt, Nancy G Saravia, Maria Adelaida Gomez

Open access · greenAbstract read
In one paragraph

Article in Acta tropica, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 28 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. MRPA-independent mechanisms of antimony resistance in Leishmania infantum.International journal for parasitology. Drugs and drug resistance · 2020
    Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Maria Claudia BarreraCentro Internacional de Entrenamiento e Investigaciones Médicas (CIDEIM), Carrera 125 No. 19-225 Cali, Colombia.
Laura Jimena RojasCentro Internacional de Entrenamiento e Investigaciones Médicas (CIDEIM), Carrera 125 No. 19-225 Cali, Colombia.
Austin WeissYale School of Medicine and Yale School of Public Health, New Haven, CT, USA.
Olga FernandezCentro Internacional de Entrenamiento e Investigaciones Médicas (CIDEIM), Carrera 125 No. 19-225 Cali, Colombia.
Diane McMahon-PrattYale School of Public Health, New Haven, CT, USA.
Nancy G SaraviaCentro Internacional de Entrenamiento e Investigaciones Médicas (CIDEIM), Carrera 125 No. 19-225 Cali, Colombia.
Maria Adelaida GomezCentro Internacional de Entrenamiento e Investigaciones Médicas (CIDEIM), Carrera 125 No. 19-225 Cali, Colombia. Electronic address: mgomez@cideim.org.co.
Centro Internacional de Entrenamiento e Investigaciones Medicas · COYale University · US

Funding

Vector/Host-Parasite Interface of Leishmaniasis in ColombiaD43TW006589 · FIC · YALE UNIVERSITY · PI GORE SARAVIA, NANCY, TSCHUDI, CHRISTIAN · 2003 to 2024
$4.3M
Macrophage drug transport and metabolism in the outcome of antileishmania therapyR01AI104823 · NIAID · CENTRO INTERNACIONAL (CIDEIM) · PI GOMEZ, MARIA ADELAIDA · 2013 to 2017
$674k
FIC NIH HHS D43 TW006589NIAID NIH HHS R01 AI104823
6 · The paper itself

Abstract

The mechanisms of Leishmania resistance to antimonials have been primarily determined in experimentally derived Leishmania strains. However, their participation in the susceptibility phenotype in field isolates has not been conclusively established. Being an intracellular parasite, the activity of antileishmanials is dependent on internalization of drugs into host cells and effective delivery to the intracellular compartments inhabited by the parasite. In this study we quantified and comparatively analyzed the gene expression of nine molecules involved in mechanisms of xenobiotic detoxification and Leishmania resistance to antimonial drugs in resistant and susceptible laboratory derived and clinical L.(Viannia) panamensis strains(n=19). In addition, we explored the impact of Leishmania susceptibility to antimonials on the expression of macrophage gene products having putative functions in transport, accumulation and metabolism of antimonials. As previously shown for other Leishmania species, a trend of increased abcc3 and lower aqp-1 expression was observed in the laboratory derived Sb-resistant L.(V.) panamensis line. However, this was not found in clinical strains, in which the expression of abca2 was significantly higher in resistant strains as both, promastigotes and intracellular amastigotes. The effect of drug susceptibility on host cell gene expression was evaluated on primary human macrophages from patients with cutaneous leishmaniasis (n=17) infected ex-vivo with the matched L.(V.) panamensis strains isolated at diagnosis, and in THP-1 cells infected with clinical strains (n=6) and laboratory adapted L.(V.) panamensis lines. Four molecules, abcb1 (p-gp), abcb6, aqp-9 and mt2a were differentially modulated by drug resistant and susceptible parasites, and among these, a consistent and significantly increased expression of the xenobiotic scavenging molecule mt2a was observed in macrophages infected with Sb-susceptible L. (V.) panamensis. Our results substantiate that different mechanisms of drug resistance operate in laboratory adapted and clinical Leishmania strains, and provide evidence that parasite-mediated modulation of host cell gene expression of molecules involved in drug transport and metabolism could contribute to the mechanisms of drug resistance and susceptibility in Leishmania.

Indexed as

AntimonyAntiprotozoal AgentsDrug ResistanceGene Expression ProfilingHost-Parasite InteractionsHumansLeishmania guyanensisLeishmaniasis, CutaneousMacrophagesAntimonyAntiprotozoal AgentsABC transporterAquaporinLeishmania Viannia panamensisMacrophageMeglumine antimoniate

Identifiers

PMID28843396
PMCPMC5633519
OpenAlexW2747731550

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.